Axiomx

Operates a recombinant antibody discovery and development services platform

placeBranford, Connecticut, United States calendar_todayFounded 2012 groups28 employees language axiomxinc.com

Innovation

6 patent families (4 granted) — focus: Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 485 times.

YearFilings
20142
20153
20166
20175
20185
20194
20202
20213
20222
20231

Investor mix

7 investors on record; lead investors include Connecticut Innovations, Elm Street Ventures.

Investor typeCountShare
Venture capital457%
Private equity114%
Other / undisclosed229%
Coming soon